Cargando…

Cerebral Blood Flow and Other Predictors of Responsiveness to Erenumab and Fremanezumab in Migraine—A Real-Life Study

INTRODUCTION: Monoclonal antibodies (mAbs) showed efficacy in migraine prevention. The aim of this study was to check if baseline clinical parameters and cerebral blood flow (CBF) measured by transcranial Doppler (TCD) may help predict mAbs efficacy. METHODS: Electronic charts of migraineurs treated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nowaczewska, Magdalena, Straburzyński, Marcin, Waliszewska-Prosół, Marta, Meder, Grzegorz, Janiak-Kiszka, Joanna, Kaźmierczak, Wojciech
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9152143/ https://www.ncbi.nlm.nih.gov/pubmed/35655615 http://dx.doi.org/10.3389/fneur.2022.895476

Ejemplares similares

Changes in Cerebral Blood Flow after Erenumab Treatment in Good and Non-Responders—A Pilot Study of Migraine Patients
por: Nowaczewska, Magdalena, et al.
Publicado: (2021)

Sinonasal symptoms in migraine without aura: results from the cross-sectional ‘Migraine in Poland’ study
por: Straburzynski, Marcin, et al.
Publicado: (2023)

Migraine symptoms, healthcare resources utilization and disease burden in a large Polish migraine cohort: Results from ‘Migraine in Poland’—a nationwide cross-sectional survey
por: Waliszewska-Prosół, Marta, et al.
Publicado: (2023)

COVID-19-related headache and sinonasal inflammation: A longitudinal study analysing the role of acute rhinosinusitis and ICHD-3 classification difficulties in SARS-CoV-2 infection
por: Straburzyński, Marcin, et al.
Publicado: (2021)

The Prevalence of Different Types of Headache in Patients with Subjective Tinnitus and Its Influence on Tinnitus Parameters: A Prospective Clinical Study
por: Nowaczewska, Magdalena, et al.
Publicado: (2020)

Erenumab in the Treatment of Comorbid Trigeminal Neuralgia in Patients With Migraine
por: Katsuki, Masahito, et al.
Publicado: (2023)

Fremanezumab for migraine
Publicado: (2020)

CGRP Inhibitors and Oxidative Stress Biomarkers in Resistant Migraine: A Real-Life Study with Erenumab, Fremanezumab, and Galcanezumab
por: De Luca, Ciro, et al.
Publicado: (2021)

Additive Interaction Between Onabotulinumtoxin-A and Erenumab in Patients With Refractory Migraine
por: Silvestro, Marcello, et al.
Publicado: (2021)

Real-world experience with monthly and quarterly dosing of fremanezumab for the treatment of patients with migraine in Japan
por: Suzuki, Shiho, et al.
Publicado: (2023)

Safety and Efficacy of Fremanezumab for the Prevention of Migraine: A Meta-Analysis From Randomized Controlled Trials
por: Gao, Bixi, et al.
Publicado: (2020)

Erenumab Impact on Sleep Assessed With Questionnaires and Home-Polysomnography in Patients With Migraine: The ERESON Study
por: Pellitteri, Gaia, et al.
Publicado: (2022)

To Eat or Not to eat: A Review of the Relationship between Chocolate and Migraines
por: Nowaczewska, Magdalena, et al.
Publicado: (2020)

The Ambiguous Role of Caffeine in Migraine Headache: From Trigger to Treatment
por: Nowaczewska, Magdalena, et al.
Publicado: (2020)

Optimal Dose of Erenumab for Preventive Treatment of Episodic Migraine: A Systematic Review and Meta-Analysis
por: Yang, Yanbo, et al.
Publicado: (2022)

Resting-State Functional Connectivity of the Ageing Female Brain—Differences Between Young and Elderly Female Adults on Multislice Short TR rs-fMRI
por: Podgórski, Przemysław, et al.
Publicado: (2021)

Fremanezumab in the treatment of migraines: evidence to date
por: Robblee, Jennifer, et al.
Publicado: (2019)

Real-world efficacy and tolerability of fremanezumab in adults with chronic migraine: a 3-month, single-center, prospective, observational study
por: Cullum, Christopher Kjaer, et al.
Publicado: (2023)

Assessment of the Effect of Erenumab on Efficacy and Quality-of-Life Parameters in a Cohort of Migraine Patients With Treatment Failure in Cyprus
por: Tziakouri, Andria, et al.
Publicado: (2021)

Gender Differences in 3-Month Outcomes of Erenumab Treatment—Study on Efficacy and Safety of Treatment With Erenumab in Men
por: Ornello, Raffaele, et al.
Publicado: (2021)

The role of erenumab in the treatment of migraine
por: Andreou, Anna P., et al.
Publicado: (2020)

Erratum: Assessment of the Effect of Erenumab on Efficacy and Quality-of-Life Parameters in a Cohort of Migraine Patients With Treatment Failure in Cyprus
por: Frontiers Production Office,
Publicado: (2021)

Erenumab for Migraine Prevention in a 1-Year Compassionate Use Program: Efficacy, Tolerability, and Differences Between Clinical Phenotypes
por: Schoenen, Jean, et al.
Publicado: (2021)

Cerebral Blood Flow in Low Intracranial Pressure Headaches—What Is Known?
por: Nowaczewska, Magdalena, et al.
Publicado: (2019)

An Evidence-Based Review of Fremanezumab for the Treatment of Migraine
por: Urits, Ivan, et al.
Publicado: (2020)

Review of Tolerability of Fremanezumab for Episodic and Chronic Migraine
por: Root, Shane, et al.
Publicado: (2023)

Fremanezumab Improved Migraine and Headache Attributed to Glioblastoma
por: Kawamura, Shin, et al.
Publicado: (2022)

Effect of switching to erenumab in non-responders to a CGRP ligand antibody treatment in migraine: A real-world cohort study
por: Overeem, Lucas Hendrik, et al.
Publicado: (2023)

Vascular safety of erenumab for migraine prevention
por: Kudrow, David, et al.
Publicado: (2020)

The unusual course of a migraine attack during COVID-19 infection — Case studies of three patients
por: Waliszewska-Prosół, Marta, et al.
Publicado: (2021)

Relationship between alcohol and primary headaches: a systematic review and meta-analysis
por: Błaszczyk, Bartłomiej, et al.
Publicado: (2023)

Fremanezumab for migraine prevention: more effective, less costly
Publicado: (2020)

One-Time Use of Galcanezumab or Fremanezumab for Migraine Prevention
por: Katsuki, Masahito, et al.
Publicado: (2023)

Migraine and Sleep—An Unexplained Association?
por: Waliszewska-Prosół, Marta, et al.
Publicado: (2021)

Assessment and characteristics of Erenumab therapy on migraine management
por: Saeed, Haitham, et al.
Publicado: (2022)

Efficiency of occlusal splint therapy on orofacial muscle pain reduction: a systematic review
por: Orzeszek, Sylwia, et al.
Publicado: (2023)

Erenumab in Chronic Migraine Patients Who Previously Failed Five First-Line Oral Prophylactics and OnabotulinumtoxinA: A Dual-Center Retrospective Observational Study
por: Raffaelli, Bianca, et al.
Publicado: (2020)

Effect of fremanezumab on quality of life and productivity in patients with chronic migraine
por: Lipton, Richard B., et al.
Publicado: (2020)

Timing and durability of response to erenumab in patients with chronic migraine
por: Tepper, Stewart J., et al.
Publicado: (2021)

Efficacy and Tolerability of Erenumab for Prevention of Episodic Migraine in India
por: Chowdhury, Debashish, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_n647d48ok0cuos195gm67f658p